Drawing for IDENTI

USPTO serial 79324042

IDENTI

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SOUDERS, MICHAEL J
Law office
TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with IDENTI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biochemical and biological preparations for scientific purposes; chemical reagents; chemicals preparations for use as reagents; chemicals, reagents and chemical preparations for use in diagnostics; in vitro diagnostic preparations and reagents for scientific and research purposes; chemicals, reagents and chemical preparations for use in tests and testing; kits and assays comprising chemicals, reagents and chemical preparations; chemical assays; kits and assays for conducting molecular analysis of biological samples comprising of chemicals, reagents and chemical preparations for scientific and research purposes; chemical products for laboratory and diagnostic use; chemical products or kits for use in relation to the detection, treatment and monitoring of cancer, inherited disease, genetic predispositions and drug responses; chemical products or kits for use in relation to the analysis and monitoring of tumours; chemicals for use in the analysis and identification of nucleic acids and nucleic acid sequences, infectious agents and pathogens; diagnostic kits comprising reagents and assays for use in relation to the analysis of DNA or RNA; none being for medical or veterinary purposesACTIVE—
005Medical and veterinary preparations and substances; chemical, biochemical and biological preparations and reagents for medical and veterinary purposes; chemical, biochemical and biological preparations and reagents for clinical diagnostic purposes; medical and veterinary diagnostic preparations and reagents; in vitro diagnostic preparations for medical and diagnostic purposes; diagnostic preparations for clinical or medical use; reagents for the treatment, monitoring or diagnosis of disease; reagents for clinical or medical use; reagents for in-vitro laboratory use for medical purposes; medical and veterinary testing preparations; chemical substances for medical laboratory analysis; chemical reagents used for medical diagnosis and analysis; kits and assays for diagnosis and testing in the medical and veterinary fields; kits and assays for conducting molecular analysis of biological samples comprising of chemicals, reagents and chemical preparations for clinical and medical purposes; diagnostic preparations or test kits for use in relation to the detection, treatment and monitoring of cancer, inherited disease, genetic predispositions, and drug responses; diagnostic preparations or test kits for use in relation to the analysis and monitoring of tumours; compounds and reagents for medical analysis and identification of nucleic acids and nucleic acid sequences, infectious agents and pathogens; diagnostic preparations or test kits for use in relation to the analysis of DNA or RNAACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 3, 2023FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 15, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 15, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 18, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 29, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 29, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 15, 2022MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 15, 2022MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 15, 2022ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 25, 2022RFNTREFUSAL PROCESSED BY IB—
May 4, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 3, 2022RFRRREFUSAL PROCESSED BY MPU—
Mar 24, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 23, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 17, 2022DOCKASSIGNED TO EXAMINER—
Nov 3, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 30, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 28, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance